BMRA - Biomerica stock slumps ~18% after hours on proposed public stock offering
- Shares of Biomerica ( NASDAQ: BMRA ) on Thursday fell 18.4% to $2.26 in postmarket trading, after the company announced a proposed public stock offering.
- All shares of common stock in the proposed offering are being offered by BMRA.
- The company said it intends to use the proceeds of the offering for general corporate purposes, including conducting clinical studies, R&D for new products and acquisitions.
- Craig-Hallum Capital Group LLC is acting as sole managing underwriter for the proposed offering.
For further details see:
Biomerica stock slumps ~18% after hours on proposed public stock offering